Receptor Occupancy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Receptor Occupancy. Real-time updates on events, politics, business and more.

Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K

January 5, 2023

January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA Disclaimers and other information Cautionary... | January 5, 2023

United States Keith Baker Craig Philips Thierry Guillaudeux Jacques Bouchy Pauline Kenny Shawn Iadonato

Source: marketscreener.com

Kineta Presents Phase 1/2 Clinical Trial Design of KVA12.1 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

November 29, 2021

/PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today a...

Jacques Bouchy Thierry Guillaudeux Society For Immunotherapy Of Cancer Kineta Inc Prnewswire Kineta Inc Anniversary Annual

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Receptor Occupancy News Today

Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K

Kineta Presents Phase 1/2 Clinical Trial Design of KVA12.1 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Explore More Categories